Lytgobi Interactions
There are 173 drugs known to interact with Lytgobi (futibatinib), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 31 are major, 139 are moderate, and 3 are minor.
- View all 173 medications that may interact with Lytgobi
- View Lytgobi alcohol/food interactions (1)
- View Lytgobi disease interactions (2)
Most frequently checked interactions
View interaction reports for Lytgobi (futibatinib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- ambrisentan
- amlodipine
- Amondys 45 (casimersen)
- apremilast
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Camzyos (mavacamten)
- Caplyta (lumateperone)
- Caprelsa (vandetanib)
Lytgobi alcohol/food interactions
There is 1 alcohol/food interaction with Lytgobi (futibatinib).
Lytgobi disease interactions
There are 2 disease interactions with Lytgobi (futibatinib) which include:
Report options
QR code containing a link to this page
More about Lytgobi (futibatinib)
- Lytgobi consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.